Ying Peng

Find an error

Name:
Organization: Institute of Materia Medica
Department: State Key Laboratory of Bioactive Substance and Function of Natural Medicines
Title:
Co-reporter:Chunyang Zhao, Weizhen Hou, Hui Lei, Longjian Huang, Shan Wang, Dandan Cui, Changhong Xing, Xiaoliang Wang, Ying Peng
Acta Pharmaceutica Sinica B 2017 Volume 7, Issue 4(Issue 4) pp:
Publication Date(Web):1 July 2017
DOI:10.1016/j.apsb.2017.04.007
A neuroinflammatory response is commonly involved in the progression of many neurodegenerative diseases. Potassium 2-(1-hydroxypentyl)-benzoate (PHPB), a novel neuroprotective compound, has shown promising effects in the treatment of ischemic stroke and Alzheimer׳s disease (AD). In the present study, the anti-inflammatory effects of PHPB were investigated in the plasma and brain of C57BL/6 mice administered a single intraperitoneal (i.p.) injection of lipopolysaccharide (LPS). Levels of iNOS and the cytokines TNFα, IL-1β and IL-10 were elevated in plasma, cerebral cortex and hippocampus after LPS injection and the number of microglia and astrocytes in cortex and hippocampus were increased. LPS also upregulated the expression of heme oxygenase-1 (HO-1) in the cortex and hippocampus. PHPB reduced the levels of iNOS and cytokines in the plasma and brain, decreased the number of microglia and astrocytes and further enhanced the upregulation of HO-1. In addition, PHPB inhibited the LPS-induced phosphorylation of ERK, P38 and JNK. These results suggest that PHPB is a potential candidate in the treatment of neurodegenerative diseases through inhibiting neuroinflammation.In this study, the neuroprotective effects of PHPB have been demonstrated in an in vivo brain injury model in mice. PHPB protected against LPS-induced neuroinflammation via inhibition of microglial activation resulting from attenuation of inflammatory cytokines, reduction of oxidative stress and downregulation of MAPK pathways.Download high-res image (158KB)Download full-size image
Co-reporter:Ruishan Wang, Ridao Chen, Jianhua Li, Xiao Liu, Kebo Xie, Dawei Chen, Ying Peng, and Jungui Dai
Journal of Natural Products 2016 Volume 79(Issue 8) pp:2143-2147
Publication Date(Web):July 28, 2016
DOI:10.1021/acs.jnatprod.6b00417
C-Prenylated xanthones are pharmacologically attractive specialized metabolites that are distributed in plants and microorganisms. The prenylation of xanthones often contributes to the structural diversity and biological activities of these compounds. However, efficient regiospecific prenylation of xanthones is still challenging. In this study, the regiospecific prenylation of a number of structurally different hydroxyxanthones (3–10) by MaIDT, a plant flavonoid prenyltransferase with substrate flexibility from Morus alba, is demonstrated. Among the enzymatic products, 2-dimethylallyl-1,3,7-trihydroxyxanthone (3a) effectively attenuated glutamate-induced injury in SK-N-SH neuroblastoma cells. These results suggest a potential approach for the synthesis of bioactive prenylated xanthones by a substrate-relaxed flavonoid prenyltransferase.
Co-reporter:Lin Yang, Zhaohua Wang, Hui Lei, Ridao Chen, Xiaoliang Wang, Ying Peng, Jungui Dai
Tetrahedron 2014 70(44) pp: 8244-8251
Publication Date(Web):
DOI:10.1016/j.tet.2014.09.033
yeso'otogirin C
Glycogen synthase kinase 3, GSK3β
Caspase-9
Cyclin-dependent kinase
Mitogen-activated protein kinase